RecruitingNCT04216732

Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

Utilization of the Natural History of Medullary Thyroid Carcinoma to Inform Advanced Disease Management


Sponsor

M.D. Anderson Cancer Center

Enrollment

2,030 participants

Start Date

Jan 10, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn about how medullary thyroid cancer develops and progresses.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Aims 1 and 2: A diagnosis of MTC
  • Aims 1 and 2: A registrant in the Medullary Thyroid Cancer Registry (MTCR). Patients of all disease phases will be eligible for enrollment
  • Aim 3: A diagnosis of advanced phase (red or gray) MTC as determined by clinical team
  • Aim 3: A current registrant in the MTCR

Interventions

OTHERBlood Pressure Measurement

Undergo blood pressure measurement

OTHERQuestionnaire Administration

Complete questionnaires


Locations(2)

University of California San Francisco

San Francisco, California, United States

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04216732


Related Trials